The problem nanoemulsions solve is deceptively simple to state and notoriously difficult to fix. Polyphenols, plant essential oils, lipophilic vitamins, and natural pigments carry impressive antioxidant and antibacterial credentials, yet their journey from laboratory bench to supermarket shelf is blocked by low water solubility, rapid thermal and photodegradation, and poor intestinal absorption. Traditional micron-scale emulsions fare little better, prone to aggregation and phase separation during long-term storage. Nanoemulsions, with droplet sizes typically below 500 nanometers, hold their ground through strong Brownian motion that counteracts gravitational separation, reinforced by electrostatic repulsion that depends on interfacial charge and solution conditions. The result is dramatically improved solubility and stability for hydrophobic bioactive compounds, along with enhanced bioavailability driven by the micellization efficiency of the lipid composition itself.

Crucially, the review insists on a rigorous definition: a food-grade nanoemulsion is a colloidal dispersion stabilized by a food-grade emulsifier in which every ingredient, from the oil phase and emulsifier to cosurfactants, solvents, polymers, and encapsulated bioactives, meets regulatory purity standards and falls within established acceptable daily intake limits. This is not an academic nicety. As nanoemulsions migrate from pharmaceutical contexts into edible products, the distinction between what works and what is legally and safely deployable becomes the central question of the field.

Because nanoemulsions are kinetically stable non-equilibrium colloids, they cannot form spontaneously from oil and water alone; they demand external energy or clever physicochemical manipulation. The review organizes fabrication strategies into two families. High-energy methods, including high-pressure homogenization, ultrasonic emulsification, microfluidization, and rotor-stator homogenization, use intense mechanical forces to shear, impact, and cavitate large droplets into nanoscale fragments, allowing emulsifiers to align in ordered fashion at the oil-water interface. Low-energy methods, including phase inversion temperature and composition techniques, self-emulsification, membrane emulsification, and solvent displacement, exploit spontaneous molecular interactions and interfacial energy minimization to assemble tiny droplets with minimal mechanical input.

Each technique carries a distinct industrial signature. High-pressure homogenization, the workhorse of large-scale production, pushes crude emulsions through narrow valves at 50 to 100 megapascals, routinely achieving droplets below 200 nanometers; researchers have used it to produce 125-nanometer pepper essential oil nanoemulsions with strengthened antibacterial activity and astaxanthin carriers with improved photostability and oral bioavailability. Its costs are equally clear: expensive equipment, high energy consumption, and shear and heat that can denature proteins, depolymerize polysaccharides, and oxidize lipids. Ultrasonic emulsification, by contrast, is cheap and simple, using cavitation bubble collapse to shatter droplets into the 50-to-150-nanometer range, but uneven acoustic energy distribution demands repeated cycles and risks localized overheating, confining it largely to laboratory research. Microfluidization, which collides pressurized fluid streams inside fixed-geometry interaction chambers, delivers precise size control and narrow distributions at 50 to 207 megapascals, yet hardware costs and microchannel blockage keep it at small scale. Rotor-stator homogenization, tolerant of viscous feedstocks and inexpensive to install, typically leaves droplets between 100 and 500 nanometers and requires supplementary homogenization to meet nanoemulsion specifications.

The low-energy family trades mechanical brutality for formulation finesse. The phase inversion temperature method exploits the temperature-dependent hydration of nonionic surfactants: as temperature rises toward the PIT, dehydration flips the surfactant’s affinity from water-loving to oil-loving, creating bicontinuous microemulsion intermediates with ultra-low interfacial tension, and rapid cooling then locks nanoscale droplets into place. The phase inversion composition method achieves the same kinetic trapping at constant temperature by systematically shifting oil, water, and surfactant ratios, yielding DHA and EPA carriers as small as 112 nanometers with narrow polydispersity. Self-emulsification, driven by chemical potential gradients when oil-surfactant mixtures contact water, offers ultra-low energy consumption and excellent scalability, with transparent sesame oil nanoemulsions around 67 nanometers demonstrating the approach’s precision. Membrane emulsification extrudes the dispersed phase through uniform nanoporous membranes to generate monodisperse droplets under mild conditions, preserving delicate bioactives, while solvent displacement dissolves lipophilic compounds in water-miscible organic solvents that diffuse away to trigger self-assembly, though residual solvent removal imposes regulatory and environmental burdens that limit food-grade scalability.

Characterization, the review argues, is where many studies fall short. Droplet size distribution and the polydispersity index, measured primarily by dynamic light scattering and laser diffraction, form the structural foundation: optimal food applications typically require droplets below 200 nanometers, generating ultrahigh specific surface area and strong electrostatic repulsion that suppress creaming and sedimentation. A curcumin nanoemulsion averaging just 19.92 nanometers with a PDI of 0.17 exemplified exceptional stability and bioavailability. Zeta potential quantifies interdroplet electrostatic repulsion, with absolute values above 30 millivolts conventionally signaling good stability, though the review cautions that sterically stabilized systems using nonionic surfactants, proteins, or polysaccharides can remain stable at low charge, so zeta potential must be read alongside interfacial composition, ionic strength, and pH. Advanced tools round out the picture: pendant-drop and spinning-drop tensiometry for interfacial tension, Fourier-transform infrared spectroscopy for molecular interactions, differential scanning calorimetry for lipid phase transitions, nuclear magnetic resonance for diffusion behavior, and X-ray photoelectron spectroscopy for surface chemistry, each with artifacts that demand careful interpretation.

The applications emerging from this toolkit span three strategic sectors. In food quality improvement, essential oil nanoemulsions have kept probiotic viability above 8 log CFU per gram in yogurt over 28 days of refrigerated storage, extended apple juice shelf life from 7 to 21 days when combined with high-pressure homogenization, delayed potato sprouting by roughly 9 days through sustained methyl salicylate release, and stretched duck meat shelf life from 14 to 35 days using ginger essential oil carriers. In packaging, nanoemulsion-loaded biodegradable films are replacing conventional plastics, which accounted for about 36 percent of global plastic production in 2015 and dominate beach litter; cinnamon essential oil films for pork now double as freshness indicators, shifting color from bright brown to saddle brown as spoilage progresses, while anthocyanin-loaded chitosan and carrageenan systems respond to ammonia from deteriorating food. In functional foods, curcumin nanoemulsions replacing margarine improved bread’s antioxidant capacity, crumb elasticity, and pore uniformity, and basil seed hydrogel nanoemulsions fortified milk powder with vitamin D3 at 115.63 international units, nearly twenty times the level in unfortified spray-dried powder.

The review’s most sobering contribution is its evidence-level honesty. Bioaccessibility measured in simulated digestion, cellular uptake in Caco-2 models, pharmacokinetics in rats, and human trials represent a hierarchy of robustness, and the field remains heavily weighted toward the preliminary end. Encouraging signals exist: excipient nanoemulsions raised quercetin bioaccessibility 1.73-fold under the INFOGEST protocol and boosted rat bioavailability by 46.6 percent with systemic antioxidant capacity up 1.47-fold, while nanoencapsulated essential oils outperformed free oils against foodborne pathogens. Yet the authors flag a pronounced translational gap for lipophilic natural pigments such as astaxanthin, lycopene, and chlorophyll, where industrial-scale validation, long-term stability data, and systematic in vivo safety evaluation are still missing. Their prescription is a formulation-to-translation framework that weighs processing stability, gastrointestinal performance, sensory quality, safety, scalability, energy demand, and production feasibility collectively rather than treating droplet size or encapsulation efficiency as standalone proof of application potential. If the field heeds that call, the tiny droplets now confined to laboratory beakers may soon determine how the world’s food stays fresh, nutritious, and honestly labeled.

Subject of Research: Fabrication, characterization, and food industry applications of food-grade nanoemulsions

Article Title: Food-related nanoemulsions: Fabrication approaches, characterization methods, and emerging applications

Article References: Zhang, Z.-H., Zhang, K., Li, X., Qin, Y., Yan, J., & Gao, X. (2026). Food-related nanoemulsions: Fabrication approaches, characterization methods, and emerging applications. Current Research in Food Science, Article 101591. https://doi.org/10.1016/j.crfs.2026.101591

Image Credits: AI Generated

DOI: Not provided

Keywords: nanoemulsions, food science, bioactive compounds, essential oils, high-pressure homogenization, phase inversion, bioavailability, food packaging, intelligent packaging, natural pigments, colloidal stability, functional foods

At Penn State, chemical engineering doctoral candidate Shreya Kapila, working in the laboratory of Andrew Zydney, Bayard D. Kunkle Chair and professor of chemical engineering, is tackling the problem at the level of the membrane surface itself. Her approach is deceptively simple: she modifies the surface properties of the membranes used to sterile filter pharmaceutical products and remove bioburden, the population of living microorganisms that must be eliminated before a drug can be considered safe. The work, published in Biotechnology Journal under the title Modulating Membrane Surface Properties via Prewetting With Polysorbate 20 to Improve Sterile Filtration of Nanoemulsions, demonstrates that a modest change in how a membrane is prepared can yield improvements in filtration capacity of more than a hundredfold in some cases.

To understand why that matters, it helps to consider what pharmaceutical products are actually up against. As Kapila explains, drug products can become contaminated with microorganisms such as bacteria and fungi, particulate matter, and other impurities introduced at different steps in manufacturing. For injectable drug products, sterility is especially critical because the product is administered directly into the patient’s body, bypassing nearly every natural defense the human body possesses. Microbial contamination in an injection can have serious, sometimes fatal, consequences, which is why regulators treat parenteral products, medicines delivered by injection, infusion or implantation, with exceptional scrutiny.

Achieving that level of safety, however, cannot come at the expense of the medicine itself. Manufacturers rely on multiple layers of control: controlled manufacturing environments, sterilized equipment, validated cleaning procedures, and processes specifically designed to prevent or remove microorganisms. At the same time, processing must not damage the product. The goal, Kapila emphasizes, is not only to achieve sterility but to preserve the chemical, physical and functional properties of the drug, including its purity, potency, physical stability, and particle or droplet size. A sterilization process that destroys every microorganism but degrades the active ingredient, or alters the size distribution of droplets in a formulation, has failed on its own terms.

The menu of available sterilization methods reflects this tension. Traditional heat sterilization can rapidly and effectively destroy microorganisms, but it is unsuitable for products that are sensitive to elevated temperatures, an increasingly common problem as biotechnology-derived medicines proliferate. Gamma irradiation offers strong penetration and can be useful for certain heat-sensitive materials, but it may degrade some formulations, including nanoemulsions, liquid formulations containing extremely small oil droplets typically ranging from roughly 20 to 200 nanometers, by increasing droplet size or otherwise destabilizing the product. Chemical sterilization may be appropriate for specific materials and applications. Aseptic processing, in which the drug is assembled from sterile components in a sterile environment, requires extensive facility validation, specialized equipment and strict personnel procedures, making it so complex and costly that manufacturers generally treat it as the last resort.

That leaves sterile filtration as the workhorse for many sensitive liquid products, including vaccines and injectable formulations with fragile active pharmaceutical ingredients. In this process, the drug product is passed through a sterilizing-grade membrane engineered to retain microorganisms while letting the therapeutic molecules or droplets pass through. The method sounds elegant, but it carries its own economic hazards. Some product inevitably remains trapped in the filter or the tubing, and when the active ingredient is expensive or available only in limited quantities, even modest losses translate into substantial financial cost. Time and cost also vary greatly across sterilization approaches; some processes are completed relatively quickly while others demand extended processing, preparation and validation, and heat-sensitive products may require specialized equipment or multi-facility aseptic operations that drive expenses higher still.

Kapila’s research focuses on the intersection of these problems: understanding, at a fundamental level, the factors that govern how nanoemulsions behave as they pass through sterilizing-grade filters. Nanoemulsions are increasingly important as platforms for vaccines and other therapeutic products, yet their tiny oil droplets are vulnerable to fouling phenomena that conventional filtration models do not fully capture. By developing a mechanistic understanding of droplet-membrane interactions, her group aims to improve existing manufacturing practices and address emerging challenges in the production of nanoemulsion-based medicines, connecting fundamental chemical engineering directly to an industry-relevant problem.

The centerpiece of the published work is a strategy that could hardly be easier to implement: prewetting the membrane surface with polysorbate 20, a common surfactant, to increase its hydrophilicity. The results were striking. Prewetting reduced pore blockage, improved the flow of nanoemulsion through the membrane, and increased filter capacity substantially, by more than 100-fold in some cases. In an industry where a single batch of a biologic can be worth millions of dollars, an intervention that multiplies the volume of product a single filter can process, while simultaneously reducing product retained in the filter, represents both a safety and an economic win. As Kapila notes, these findings show that relatively simple surface modification strategies can remarkably improve filtration efficiency and product yield.

The research also illustrates how academic-industrial collaboration can accelerate solutions to manufacturing problems. Kapila joined Zydney’s group at a time when it was working with Merck on a real-world challenge in pharmaceutical manufacturing, an experience she credits with allowing her to study membrane filtration from both a scientific and an applied perspective and to contribute to research directly relevant to pharmaceutical development. She later completed a five-month co-op at GlaxoSmithKline, gaining hands-on experience applying technical knowledge in an industry setting and deepening her understanding of how pharmaceutical manufacturing actually operates at scale.

Beyond the laboratory and the plant floor, Kapila has presented her work at symposia hosted by Penn State’s J. Jeffrey and Ann Marie Fox Graduate School and the Robert V. Waltemeyer Department of Chemical Engineering, and at several international conferences, sharing her findings with researchers and professionals from around the world. She has served as a teaching assistant and mentored undergraduate researchers, experiences she says sharpened her communication, organization and collaboration skills while reinforcing how fundamental research can ultimately make pharmaceutical manufacturing more efficient, more reliable and more capable of delivering safe products to patients. In a field where the difference between a clean membrane and a fouled one can be measured in lives as well as dollars, that pipeline from bench science to bedside safety has rarely mattered more.

Subject of Research: Surface modification of sterilizing-grade filtration membranes to improve sterile filtration of pharmaceutical nanoemulsions

Article Title: Q&A: The safety and sterilization of pharmaceuticals manufacturing

Article References: Q&A: The safety and sterilization of pharmaceuticals manufacturing. (n.d.). Original publication

Image Credits: AI Generated

DOI: Not provided

Keywords: sterile filtration, pharmaceutical manufacturing, membrane technology, nanoemulsions, polysorbate 20, aseptic processing, bioburden, drug safety, vaccines, surface modification, Biotechnology Journal, Penn State

The appeal of entomopathogenic nematodes, or EPNs, is easy to understand. Species in the genera Steinernema and Heterorhabditis are found on every continent except Antarctica, and they infect a remarkably broad range of insect hosts. Once infective juvenile nematodes locate a suitable host, they enter through natural openings such as the mouth, anus, or spiracles, and release their bacterial symbionts, Xenorhabdus in Steinernema and Photorhabdus in Heterorhabditis. These bacteria multiply rapidly inside the insect’s hemocoel, killing the host within a matter of days through septicemia, while simultaneously creating conditions that allow the nematodes to reproduce. Under recommended application conditions, EPNs generally show low adverse effects on non-target organisms, making them compatible with the ecological principles that underpin integrated pest management programs.

Yet for all their promise, EPNs have struggled to become mainstream tools in large-scale agriculture, and the reasons are largely environmental. The infective juvenile stage, which is the form applied in the field, is exquisitely sensitive to the conditions it encounters after leaving the production facility. Ultraviolet radiation from sunlight can kill nematodes within minutes of exposure. Desiccation is equally lethal, since these organisms require a film of moisture to move, breathe, and infect. Temperature extremes, both hot and cold, degrade their survival and infectivity, and once applied to soil, nematode persistence can decline rapidly, leaving pests unprotected before the crop cycle ends. Storage and delivery add further complications, as live biological products demand cold chains and careful handling that conventional chemical pesticides do not. These constraints translate into higher application frequencies, inconsistent field performance, and a cost structure that often loses out to synthetic insecticides.

This is precisely where nanotechnology enters the picture. The Indian review team surveys a growing toolbox of nano-based formulations, including nanoemulsions, nanocarriers, and nano-based coatings, that can be used to protect EPNs and enhance their insecticidal potential. The core idea is elegantly simple: wrap the living biological agent, or the active compounds associated with it, in engineered materials so small that they interact with the environment in fundamentally different ways than bulk formulations. Nanoscale carriers can shield nematodes from harsh ultraviolet light, buffer them against temperature swings, and slow the loss of moisture that would otherwise prove fatal. In doing so, they extend the window of activity that determines whether a nematode application succeeds or fails in the field.

The technical mechanisms behind this protection draw on well-established principles of materials science. Nanoemulsions, for example, are kinetically stable mixtures of oil and water stabilized by surfactants, with droplet sizes typically in the tens to hundreds of nanometers. At this scale, the interfacial area between phases becomes enormous, allowing active ingredients to be dispersed uniformly and delivered efficiently. Nanocarriers, including polymeric nanoparticles and other encapsulation systems, can be engineered to release their payloads in a controlled and targeted manner, responding to environmental triggers such as moisture, pH, or temperature. Nano-based coatings applied directly to nematodes or to the substrate carrying them can create a protective microenvironment around the infective juveniles, reducing desiccation stress during application and in the hours that follow. The review emphasizes that such systems permit controlled, targeted, and target-specific release, which means the biological agent is delivered where and when it is needed rather than being wasted on the surrounding environment.

The practical consequences of this integration could be significant. According to the review, nano-enhanced EPN formulations have the potential to improve nematode survival, stability, and infectivity simultaneously, leading to improved pest management efficiency even at reduced application frequencies. For farmers, fewer applications mean lower labor costs, less machinery time, and reduced disruption to soil ecosystems. For the environment, it means smaller quantities of biological material and carrier substances released per unit of crop protected. The authors frame this within the broader transition from chemical to green pest management, noting that the integrated approach aligns with the principles of eco-friendly and sustainable agriculture by reducing dependency on chemical insecticides and supporting integrated pest management programs. In an era when pesticide residues, resistance development in pests such as Spodoptera species, and health risks to farmworkers are drawing increasing scrutiny, the timing of such innovations is hardly accidental.

The review does not stand in isolation. It builds on a substantial body of recent research documenting both the promise and the pitfalls of nanopesticides more broadly. Studies of nanoencapsulated botanical insecticides, such as neem oil nanoemulsions, have demonstrated that nanoscale delivery can dramatically improve the performance of naturally derived active ingredients. Work on polymeric nanocarriers for pesticides like abamectin has shown that surface functionalization can enhance foliar retention and adhesion, keeping the active compound on the plant where it is needed. Chitin nanocrystal Pickering emulsions have been developed for pesticide microencapsulation with superior leaf adhesion and enhanced safety profiles. Even RNA interference technology, one of the most talked-about frontiers in crop protection, depends on nanocarriers and polymer systems to deliver double-stranded RNA into insect cells. The lesson across all of these platforms is consistent: nanotechnology excels at protecting fragile active ingredients from degradation and delivering them precisely to their targets, and EPNs are arguably the most fragile and most precisely targeted biological agents in the entire biocontrol arsenal.

However, the review is careful not to paint an uncritically rosy picture, and the challenges it identifies are substantial. Environmental safety remains a primary concern, since engineered nanomaterials introduced into soil ecosystems may interact with microorganisms, earthworms, and other non-target organisms in ways that are not yet fully understood. Research on silver nanoparticles and carbon nanotubes in aquatic systems has documented toxicity to fish and other organisms, underscoring that nanoscale does not automatically mean benign. Production costs present another hurdle, as nanoformulations must compete economically with cheap, mass-produced chemical insecticides if they are to achieve widespread adoption, particularly in the developing world where the majority of food production occurs. Regulatory approvals add a further layer of complexity, since many jurisdictions lack clear frameworks for evaluating products that combine living biological agents with engineered nanomaterials. The authors stress that these challenges must be handled carefully, and that constant research and field validation are essential before the combined potential of EPNs and nanotechnology can be realized in practice.

What emerges from the review is a vision of pest management that looks radically different from the spray-and-hope model of the twentieth century. In this vision, a farmer applies a formulation containing nematodes armored against UV radiation and desiccation by nanoscale coatings, carried in a delivery system that releases them gradually into the root zone where soil-borne pests feed. The nematodes survive longer, disperse more effectively, and kill more insects per application, while the surrounding soil community remains largely undisturbed. The symbiotic bacteria within the nematodes do the lethal work that chemical insecticides once did, but without the residues, the resistance treadmill, or the documented health risks to farmworkers and their families that have been associated with prolonged pesticide exposure. It is a system that borrows the precision of modern drug delivery and applies it to the oldest form of pest control imaginable: one organism killing another.

Whether that vision becomes reality will depend on the hard, unglamorous work of field trials, cost engineering, and regulatory negotiation that lies ahead. The review by Guleria and colleagues makes clear that the scientific foundations are in place, with decades of research on EPN biology, formulation science, and nanomaterial engineering converging at a moment when agriculture desperately needs alternatives to chemical insecticides. The next-generation formulations the authors describe, from nanoemulsions to smart coatings, are no longer laboratory curiosities but emerging products at the frontier of a nanobiopesticide industry that is expanding rapidly. If the remaining challenges of environmental safety testing, production scaling, and regulatory harmonization can be resolved, the marriage of microscopic worms and engineered nanoparticles may prove to be one of the most consequential developments in sustainable agriculture of the coming decade, turning what was once a niche biological control tool into a cornerstone of global food security.

Subject of Research: Integration of nanotechnology with entomopathogenic nematodes for sustainable insect pest management

Article Title: Integrating entomopathogenic nematodes and nanotechnology for next-generation insect pest management

Article References: Guleria, A., Thakur, H., Kumari, S., & Thakur, N. (2026). Integrating entomopathogenic nematodes and nanotechnology for next-generation insect pest management. Journal of Nanoparticle Research, 28(9), Article 234. https://doi.org/10.1007/s11051-026-06760-5

Image Credits: AI Generated

DOI: 10.1007/s11051-026-06760-5

Keywords: entomopathogenic nematodes, nanotechnology, biopesticides, integrated pest management, nanoemulsions, nanocarriers, sustainable agriculture, soil-borne pests, biological control, Steinernema, Heterorhabditis, precision agriculture

The problem the researchers set out to solve is a familiar one in the age of antibiotic resistance. Staphylococcus aureus is a common resident of the human nasal cavity and skin, but when it colonizes persistently, it can drive severe chronic rhinosinusitis, a debilitating inflammation of the nasal passages and sinuses. Worse, the bacterium increasingly shrugs off frontline drugs such as methicillin and amoxicillin, and it has a second line of defense: the ability to grow in aggregated communities called biofilms, which are sheathed in protective extracellular polymers. These biofilms can tolerate antibiotics at concentrations up to 1,000 times higher than what kills free-floating planktonic cells, making chronic infections notoriously difficult to eradicate and frequently leading to treatment failure.

Essential oils, the concentrated aromatic extracts of medicinal and aromatic plants, have long been known to possess antimicrobial properties. Roughly 85 percent of traditional crude medicines are plant-derived, and around 60 percent of the world’s population still relies on plant-based remedies for primary healthcare. Yet essential oils suffer from a fundamental chemical handicap: they are highly hydrophobic, meaning they dissolve poorly in water, permeate cells inefficiently, and show low bioavailability. In laboratory tests, their high viscosity and poor miscibility in growth media can even lead to inaccurate assessments of their true antimicrobial power. This solubility barrier has kept many promising plant oils out of serious clinical consideration despite centuries of traditional use.

The team, led by researchers affiliated with the University of Adelaide and the Basil Hetzel Institute in South Australia, focused on three plants with rich ethnobotanical histories. Eremophila mitchellii, known as false sandalwood, was used by indigenous Australians to treat colds, fevers, and rheumatism. Artemisia vulgaris, or mugwort, and Rhododendron anthopogon have been staples of Himalayan and traditional herbal medicine, valued for their antimicrobial, anti-inflammatory, and respiratory benefits, with the rhododendron oil traditionally serving as a cough medicine. Oils were sourced from Nepal and South Australia and formulated into oil-in-water nanoemulsions using the FDA-approved surfactant Pluronic F127 and the cosurfactant propylene glycol, with probe sonication producing droplets small enough to behave very differently from bulk oil.

The physicochemical characterization revealed just how successful the formulation was. All three nanoemulsions displayed average droplet diameters below 240 nanometers, with the Eremophila formulation measuring around 230 nanometers, the Artemisia around 217 nanometers, and the Rhododendron around 193 nanometers. Polydispersity index values, a measure of size uniformity, all came in below 0.3, indicating well-distributed droplet populations. Crucially, the nanoemulsions remained physically stable for up to six months of refrigerated storage, with minimal changes to their size, charge, and uniformity. This shelf stability matters enormously for any future pharmaceutical application, since many colloidal formulations degrade or separate within days.

The antibacterial results were striking. Against the standard laboratory strain and two multidrug-resistant clinical isolates recovered from chronic rhinosinusitis patients, the crude essential oils required concentrations ranging from 16 to more than 512 milligrams per milliliter to inhibit growth. Once nanoemulsified, those requirements plummeted. The Eremophila mitchellii nanoemulsion proved the star performer, inhibiting bacterial growth at concentrations of 1 milligram per milliliter or less, an improvement of at least sixteen-fold over the raw oil. The Rhododendron nanoemulsion showed minimum inhibitory concentrations of 4 to 8 milligrams per milliliter, while the Artemisia formulation required somewhat higher doses. Notably, the blank emulsion containing only the surfactants showed no antibacterial activity whatsoever, confirming that the enhancement came from better delivery of the oils themselves rather than the excipients.

Against established biofilms, the nanoemulsions delivered the study’s most dramatic results. When the Eremophila nanoemulsion was applied at 10 milligrams per milliliter, bacterial viability within biofilms dropped by 3.5 to 8.3 orders of magnitude depending on the strain, with complete eradication observed in some clinical isolates. The Artemisia and Rhododendron nanoemulsions each achieved reductions of roughly three to four orders of magnitude. Confocal microscopy using live-dead staining confirmed the dose-dependent kill, showing that at 10 milligrams per milliliter of the Eremophila nanoemulsion, no living cells remained in the biofilm. Scanning electron microscopy went further, revealing biofilm matrices torn apart and individual staphylococcal cells visibly distorted, with damaged cell surfaces and walls, in stark contrast to the plump, round morphology of untreated control bacteria.

The mechanism, the researchers propose, hinges on physics as much as chemistry. The ultrafine droplets of a nanoemulsion carry an enormous surface-to-volume ratio, presenting far more antimicrobial molecules to the bacterial cell wall than a viscous droplet of bulk oil ever could. The team suggests that while crude oil can only attack the top layer of a biofilm where bacteria make direct contact, nanoemulsified active compounds can diffuse through the biofilm matrix and reach bacteria buried deep within. The negatively charged droplets may also fuse electrostatically with bacterial membranes, destabilizing them and disrupting metabolic processes. The Eremophila nanoemulsion carried the strongest negative zeta potential at minus 18.4 millivolts, which the authors suggest may partly explain its superior antibiofilm performance. Because essential oils contain dozens of compounds acting in synergy, improved solubility likely raises the delivered concentration of multiple bioactive constituents simultaneously.

Safety data offered cautious encouragement. Using an MTT assay on human foreskin fibroblast cells, the team found that the Artemisia nanoemulsion maintained more than 90 percent cell viability even at 64 milligrams per milliliter, well above its effective antibacterial dose, and retained over 60 percent viability at double that concentration. The Eremophila and Rhododendron nanoemulsions showed dose- and time-dependent toxicity, with viability falling below 60 percent at their higher test concentrations, a signal that dosing windows will need careful optimization. The authors also note a technical caveat: some essential oil components may interfere with the MTT dye itself, potentially producing false toxicity readings, so ex vivo and in vivo studies will be essential to establish the true safety profile of these formulations.

The implications reach well beyond sinusitis. The researchers argue that nanoemulsification overcomes the core limitations that have sidelined essential oils, including poor solubility, high viscosity, and inconsistent biological activity, while preserving the synergistic interplay of their complex chemistry. All excipients used are FDA-approved food additives, and the formulation process is straightforward enough to scale. If future animal and clinical studies validate these in vitro findings, nanoemulsified plant oils could emerge as topical or localized treatments for biofilm-driven infections of the skin, wounds, and airways, offering a non-antibiotic weapon in the fight against resistant bacteria while opening new markets for producers of traditional medicinal oils around the world.

Subject of Research: Nanoemulsion-enhanced antibacterial and antibiofilm activity of plant essential oils against multidrug-resistant Staphylococcus aureus

Article Title: Nanoemulsification Promotes Antibacterial Activity of Selected Essential Oils Against Multidrug‐Resistant Staphylococcus aureus Biofilms In Vitro

Article References: Karki, S., Ramezanpour, M., Cooksley, C. M., Barry, E., Prestidge, C. A., Nepal, R., Feizi, S., Correll, D., Wormald, P.-J., Vreugde, S., & Awad, M. (2026). Nanoemulsification Promotes Antibacterial Activity of Selected Essential Oils Against Multidrug‐Resistant Staphylococcus aureus Biofilms In Vitro. MicrobiologyOpen, 15(5), Article e70407. https://doi.org/10.1002/mbo3.70407

Image Credits: AI Generated

DOI: 10.1002/mbo3.70407

Keywords: nanoemulsion, essential oils, Staphylococcus aureus, biofilm, antimicrobial resistance, chronic rhinosinusitis, Artemisia vulgaris, Eremophila mitchellii, Rhododendron anthopogon, nanotechnology, cytotoxicity, drug delivery